• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
81,757.73 -501.51
( -0.61%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.85 3.30
( 0.01%)
Global Indices
Nasdaq
44,363.41 142.09
(-0.32%)
Dow Jones
6,317.35 -1.01
(-0.02%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,992.12 19.48
(0.22%)
Forex
USD-INR
85.99 0.08
(0.09%)
EUR-INR
99.75 -0.09
(-0.09%)
GBP-INR
115.25 0.11
(0.09%)
JPY-INR
0.58 0.00
(0.02%)

EQUITY - MARKET SCREENER

Gujarat Terce Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524314
INE499G01013
8.7331536
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
36.73
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

srg fingrow finance ltd
Exide Industries Ltd - Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2025.
Jul 01,2025
Exide Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve approval of unaudited financial results of the Company for the quarter ended 30th June 2025.